These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16755198)

  • 1. Hypertensive renal vascular disease and cardiovascular endpoints.
    Matavelli LC; Zhou X; Frohlich ED
    Curr Opin Cardiol; 2006 Jul; 21(4):305-9. PubMed ID: 16755198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia.
    Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G
    Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minor abnormalities of renal function: a situation requiring integrated management of cardiovascular risk.
    Segura J; Ruilope LM
    Fundam Clin Pharmacol; 2005 Aug; 19(4):429-37. PubMed ID: 16011729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
    Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE
    J Nephrol; 2008; 21(4):566-9. PubMed ID: 18651547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension.
    Zoccali C
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S61-3. PubMed ID: 16565249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the use of urinary albumin as marker of kidney involvement in unselected populations.
    McQueen MJ
    Scand J Clin Lab Invest Suppl; 2008; 241():52-6. PubMed ID: 18569965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?
    Johnson RJ; Segal MS; Srinivas T; Ejaz A; Mu W; Roncal C; Sánchez-Lozada LG; Gersch M; Rodriguez-Iturbe B; Kang DH; Acosta JH
    J Am Soc Nephrol; 2005 Jul; 16(7):1909-19. PubMed ID: 15843466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild hyperuricemia and subclinical renal damage in untreated primary hypertension.
    Viazzi F; Leoncini G; Ratto E; Falqui V; Parodi A; Conti N; Derchi LE; Tomolillo C; Deferrari G; Pontremoli R
    Am J Hypertens; 2007 Dec; 20(12):1276-82. PubMed ID: 18047917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inflammation, oxidative stress and kidney function in arterial hypertension].
    Cerasola G; Guarneri M; Cottone S
    G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
    J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
    Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
    Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension, microalbuminuria and renal dysfunction: the Renal Dysfunction in Hypertension (REDHY) study.
    Cerasola G; Mulè G; Cottone S; Nardi E; Cusimano P
    J Nephrol; 2008; 21(3):368-73. PubMed ID: 18587725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary hypertension and nephropathy.
    Rosario RF; Wesson DE
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):130-4. PubMed ID: 16481878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does essential hypertension cause progressive renal disease?
    Fliser D; Ritz E
    J Hypertens Suppl; 1998 Sep; 16(4):S13-5. PubMed ID: 9817187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac biomarkers in chronic renal disease.
    Collinson PO; Gaze DC
    Scand J Clin Lab Invest Suppl; 2008; 241():104-8. PubMed ID: 18569976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patients.
    Uno H; Ishikawa J; Hoshide S; Kabutoya T; Ishikawa S; Shimada K; Kario K
    Hypertens Res; 2008 May; 31(5):887-96. PubMed ID: 18712044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of albuminuria in hypertensive patients.
    Ritz E; Fliser D
    Clin Investig; 1992; 70 Suppl 1():S114-9. PubMed ID: 1591503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease as a situation of high added risk in hypertensive patients.
    Segura J; García-Donaire JA; Praga M; Ruilope LM
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S136-40. PubMed ID: 16565238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.